Sana Biotechnology, Inc. License Agreements

41 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 5 to Option and License Agreement by and between the Company and Beam Therapeutics Inc., dated as of October 15, 2024
License Agreements
Sana Biotechnology, Inc.
Biotechnology
2025
Sixth Amendment to License Agreement by and between the Company and President and Fellows of Harvard College, dated as of August 28, 2024
License Agreements
Sana Biotechnology, Inc.
Biotechnology
MA
2024
Amendment No. 2 to Amended and Restated License Agreement by and between the Company and the University of Rochester, dated as of May 30, 2024
License Agreements
Sana Biotechnology, Inc.
Biotechnology
2024
Second Amendment to Exclusive License Agreement by and between the Company and The Regents of the University of California acting through the Technology Development Group of The...
License Agreements
Sana Biotechnology, Inc.
Biotechnology
2024
Amendment No. 4 to Option and License Agreement by and between the Company and Beam Therapeutics Inc., dated as of April 4, 2024
License Agreements
Sana Biotechnology, Inc.
Biotechnology
2024
Amendment No. 1 to Amended and Restated Exclusive Patent License Agreement by and between the Company and Rochester, dated as of December 30, 2022
License Agreements
Sana Biotechnology, Inc.
Biotechnology
2024
First Amendment to Exclusive License Agreement by and between the Company and The Regents acting through The Technology Development Group of UCLA, dated as of May 21, 2021
License Agreements
Sana Biotechnology, Inc.
Biotechnology
2024
Amendment No. 3 to Option and License Agreement by and between the Company and Beam Therapeutics Inc., dated as of March 17, 2023
License Agreements
Sana Biotechnology, Inc.
Biotechnology
2023
Amendment No. 2 to Non-Exclusive License and Development Agreement by and between the Company and FCDI, dated as of October 26, 2021
License Agreements
Sana Biotechnology, Inc.
Biotechnology
2023
Amendment No. 1 to Non-Exclusive License and Development Agreement by and between the Company and FCDI, dated as of April 12, 2021
License Agreements
Sana Biotechnology, Inc.
Biotechnology
2023
Fifth Amendment to License Agreement by and between the Company and Harvard, dated as of February 9, 2023
License Agreements
Sana Biotechnology, Inc.
Biotechnology
MA
2023
Amendment No. 11 to Exclusive Start-Up License Agreement by and between the Company and UW, dated as of July 14, 2022
License Agreements
Sana Biotechnology, Inc.
Biotechnology
2022
Amendment No. 10 to Exclusive Start-Up License Agreement by and between the Company and UW, dated as of October 30, 2021
License Agreements
Sana Biotechnology, Inc.
Biotechnology
2022
Amendment No. 9 to Exclusive Start-Up License Agreement by and between the Company and UW, dated as of September 9, 2021
License Agreements
Sana Biotechnology, Inc.
Biotechnology
2022
Amendment No. 8 to Exclusive Start-Up License Agreement by and between the Company and UW, dated as of July 20, 2021
License Agreements
Sana Biotechnology, Inc.
Biotechnology
2022
Amendment No. 7 to Exclusive Start-Up License Agreement by and between the Company and UW, dated as of April 14, 2021
License Agreements
Sana Biotechnology, Inc.
Biotechnology
2022
Amendment No. 6 to Exclusive Start-Up License Agreement by and between the Company and UW, dated as of March 11, 2021
License Agreements
Sana Biotechnology, Inc.
Biotechnology
2022
Amendment No. 5 to Exclusive Start-Up License Agreement by and between the Company and University of Washington (UW), dated as of February 25, 2021
License Agreements
Sana Biotechnology, Inc.
Biotechnology
2022
Amendment No. 2 to Option and License Agreement by and between the Company and Beam Therapeutics Inc., dated as of July 19, 2022
License Agreements
Sana Biotechnology, Inc.
Biotechnology
2022
Amendment No. 1 to Option and License Agreement, by and between the Company and Beam Therapeutics Inc., dated as of June 6, 2022
License Agreements
Sana Biotechnology, Inc.
Biotechnology
NY
2022
Patent License Agreement by and between the Company and the U.S. Department of Health and Human Services, as represented by The National Cancer Institution, an institute of the...
License Agreements
Sana Biotechnology, Inc.
Biotechnology
2022
Fourth Amendment to License Agreement by and between the Company and Harvard, dated as of October 25, 2021
License Agreements
Sana Biotechnology, Inc.
Biotechnology
MA
2022
Third Amendment to License Agreement by and between the Company and Harvard, dated as of May 20, 2021
License Agreements
Sana Biotechnology, Inc.
Biotechnology
MA
2022
Option and License Agreement, effective October 15, 2021, by and between the Company and Beam Therapeutics Inc
License Agreements
Sana Biotechnology, Inc.
Biotechnology
NY
2021
Non-Exclusive License and Development Agreement by and between the Registrant and Fujifilm Cellular Dynamics, Inc., effective on February 1, 2021
License Agreements
Sana Biotechnology, Inc.
Biotechnology
WI
2021
Amendment No. 4 to Exclusive Start-Up License Agreement, effective on January 21, 2021 by and between the Registrant and UW
License Agreements
Sana Biotechnology, Inc.
Biotechnology
2021
Amendment No. 2 to Exclusive Start-Up License Agreement, effective on July 16, 2020, by and between Cytocardia and UW
License Agreements
Sana Biotechnology, Inc.
Biotechnology
2021
Assignment of Exclusive Start-Up License Agreement, effective on November 11, 2020, by and among UW, Cytocardia and the Registrant
License Agreements
Sana Biotechnology, Inc.
Biotechnology
2021
Amendment No. 1 to Exclusive Start-Up License Agreement, effective on November 6, 2019, by and between Cytocardia and UW
License Agreements
Sana Biotechnology, Inc.
Biotechnology
2021
Exclusive Start-Up License Agreement, effective on October 9, 2018, by and between Cytocardia, Inc. (Cytocardia) and the University of Washington, acting through UW CoMotion (UW)
License Agreements
Sana Biotechnology, Inc.
Biotechnology
WA
2021
Amended and Restated Exclusive Patent License Agreement, dated September 10, 2020, by and among the Registrant, Oscine Corp., and University of Rochester
License Agreements
Sana Biotechnology, Inc.
Biotechnology
NY
2021
Exclusive License Agreement, effective on September 1, 2020, by and between the Registrant and Washington University
License Agreements
Sana Biotechnology, Inc.
Biotechnology
NY
2021
Exclusive License Agreement, effective on November 14, 2019, by and between the Registrant and Washington University
License Agreements
Sana Biotechnology, Inc.
Biotechnology
NY
2021
Amendment No. 1 to Exclusive License Agreement, effective on December 3, 2020, by and between the Registrant and UCSF
License Agreements
Sana Biotechnology, Inc.
Biotechnology
2021
Exclusive License Agreement, effective on January 2, 2019, by and between the Registrant and The Regents, acting through its Office of Technology Management, University of...
License Agreements
Sana Biotechnology, Inc.
Biotechnology
DE
2021
Amendment No. 2 to License Agreement, dated as of December 15, 2020, by and between the Registrant and Harvard
License Agreements
Sana Biotechnology, Inc.
Biotechnology
MA
2021
Amendment No. 1 to License Agreement, dated as of June 10, 2019, by and between the Registrant and Harvard
License Agreements
Sana Biotechnology, Inc.
Biotechnology
2021
License Agreement, dated as of March 19, 2019, by and between the Registrant and President and Fellows of Harvard College (Harvard)
License Agreements
Sana Biotechnology, Inc.
Biotechnology
MA
2021
Exclusive License Agreement, dated March 22, 2019, by and between the Registrant and the Regents of the University of California (The Regents) acting through the Technology...
License Agreements
Sana Biotechnology, Inc.
Biotechnology
CA
2021
First Amendment to License Agreement, dated as of February 14, 2019, by and between Flagship Innovations V and Cobalt
License Agreements
Sana Biotechnology, Inc.
Biotechnology
MA
2021